Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations

A Pines1, V Mijatovic, M J van der Mooren

  • 1Department of Medicine T, Ichilov Medical Center, Tel Aviv, Israel.

European Journal of Obstetrics, Gynecology, and Reproductive Biology
|February 1, 1997
PubMed
Summary

Hormone replacement therapy (HRT) with estrogen, even with progestin, significantly reduces cardiovascular disease risk in postmenopausal women. Estrogen promotes vasodilation and improves coronary stenosis, supporting its recommendation for cardiovascular health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Room temperature "optical nanodiamond hyperpolarizer": Physics, design, and operation.

The Review of scientific instruments·2020
Same author

Hyperpolarized relaxometry based nuclear T<sub>1</sub> noise spectroscopy in diamond.

Nature communications·2019
Same author

Wide dynamic range magnetic field cycler: Harnessing quantum control at low and high fields.

The Review of scientific instruments·2019
Same author

Enhanced dynamic nuclear polarization via swept microwave frequency combs.

Proceedings of the National Academy of Sciences of the United States of America·2018
Same author

No increased death toll for long-term menopausal hormone therapy.

Climacteric : the journal of the International Menopause Society·2017
Same author

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

Climacteric : the journal of the International Menopause Society·2017

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Women's Health

Background:

  • Menopause is associated with changes in cardiovascular risk factors.
  • Estrogen therapy has shown potential cardioprotective effects.
  • Hormone replacement therapy (HRT) involves estrogen, often with progestin.

Purpose of the Study:

  • To review the evidence on hormone replacement therapy (HRT) and its effects on cardiovascular disease (CVD) in postmenopausal women.
  • To elucidate the mechanisms by which estrogen may confer cardioprotection.
  • To assess the impact of HRT on cardiovascular risk factors and outcomes.

Main Methods:

  • Review of epidemiological studies and clinical trials, including the PEPI-trial.
  • Analysis of HRT's effects on vascular endothelial cells and the vessel wall.

Related Experiment Videos

  • Examination of HRT's impact on nitric oxide (NO) synthesis and vasodilation.

    • Main Results:

    • Epidemiological data indicate estrogen use reduces CVD incidence by up to 50%.
    • Estrogen enhances vasodilation by promoting nitric oxide release and inhibiting vasoconstriction.
    • Estrogen monotherapy reduced coronary stenosis in postmenopausal women with ischemic heart disease.
    • HRT, including with progestin, did not significantly attenuate estrogen's cardioprotective effects or majorly impact blood pressure.

    Conclusions:

    • HRT, particularly estrogen therapy, demonstrates promising cardioprotective effects in postmenopausal women.
    • Estrogen's mechanisms involve improving vascular function and reducing coronary stenosis.
    • HRT is recommended for healthy postmenopausal women, those with existing CVD, and those at increased CVD risk.